InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Explore the full record of transactions filed by Walker Neal, Chairman & CEO. Officer active across 1 companies, notably Aclaris Therapeutics, Inc.. Cumulatively, 9 reports have been logged. Total volume traded: €1.2m. The latest transaction was disclosed on 21 April 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
€351,58425,000 shares@ €14.06340.056% mcap28.2% of flow
Common Stock
SEC:0001209191-22-025537:0·
€813,55556,303 shares@ €14.44960.13% mcap65.4% of flow
Common Stock
SEC:0001209191-22-018516:0·
96,150 shares
Common Stock
SEC:0001209191-22-015794:0·
€39,8503,595 shares@ €11.08480.0063% mcap100.0% of flow
Common Stock
SEC:0001209191-22-008837·
€39,8503,595 shares@ €11.08480.0063% mcap3.2% of flow
Common Stock
SEC:0001209191-22-008837:0·
10,800 shares
Common Stock
SEC:0001209191-22-006826:0·
10,800 shares
Common Stock
SEC:0001209191-22-006826·
73,015 shares
Common Stock
SEC:0001209191-21-037473·
73,015 shares
Common Stock
SEC:0001209191-21-037473:0·
9 of 9 declarations
About Walker Neal
Neal Walker is the Chairman and CEO of Aclaris Therapeutics, Inc. He leads the company by defining the strategic vision and overseeing all operations. His role includes managing human resources, business development, and communication with shareholders. Through his leadership, he ensures that the company remains competitive in the market and meets the needs of its clients while achieving its financial objectives.
